TBA The Biotechnology Initiative

The Voice of Bioscience in Ontario

NEWS

SPONSORS

Flash Slideshow

 


Member Press Releases

March 15 2010 Pfizer Animal Health exercises licensing option release
Immunovaccine Inc. (TSX-V:IMV) is pleased to announced today that Pfizer Animal Health will exercise a licensing option to use our vaccine enhancement and delivery platform in the development of a third livestock vaccine.
December 15 2009 World Courier Achieves Coveted GxP-Compliant Status Worldwide with Focus on GDP, Quality Management
With a fully GxP-compliant transport and supply chain system in place, World Courier meets the most demanding industry requirements for managing time- and temperature-sensitive clinical trial materials used in global studies.
December 09 2009 Government of Ontario invests in agriculture with new IQF Facility
Announced today in Delhi, Ontario, the government of Ontario through the Ontario Ministry of Agriculture, Food and Rural Affairs has partnered with Naturally Norfolk, a Delhi-based company specializing in the processing of frozen fruits and vegetables, to launch the development of a new Individual Quick Freeze (IQF) facility in this south central Ontario community.
October 07 2009 Agricultural diversity can provide many solutions to energy needs
National Biotechnology Week is a celebration of life sciences’ contributions to society, showing how new advances are affecting our every day lives. From health to the bioeconomy to the environment, biotechnology and life sciences developments have clearly addressed many of society’s needs. The Biotechnology Initiative (TBI) believes that knowledge is a key driver to technology use, and that education is key to informed decisions about policy.
October 01 2009 Amorfix Appoints Dr. Philippe Couillard to it's Board of Directors
TORONTO, ON - Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, announced today that Philippe Couillard, MD, former Minister of Health and Social Services for Quebec, has been appointed to its Board of Directors.

September 25 2009 Government of Canada Invests in Research on Anti-Viral Drugs
The Government of Canada is investing $2 million to support the International Consortium on Anti-Virals, a Canadian-based consortium of scientists who conduct research on low-cost antiviral therapies that can be used to combat viral infections including influenza.
September 25 2009 ICAV/CITAV Receives Second Round of Funding From Public Health Agency of Canada
Dean Del Mastro MP (Peterborough)announced today that the International Consortium on Anti-Virals/Consortium International sur les Therapies Antivirales will receive $2 million over the next two years.
September 28 2009 Notes For A Statement To The Legislature
By the honourable John Milloy Minister of Research and Innovation & Minister of Training, Colleges and Universities on recognizing National Biotechnology Week.
August 28 2009 Promoting Bioscience education across Canada
The Canadian Biotechnology Education Resource Centre (CBERC) is changing its name to Bioscience Education Canada (BEC) in recognition of the expanding role of biotechnology in many fields of biological science.
July 16 2009 Moose and Mountains
Moose and Mountains is a great resource for explaining the issues and opportunities in the life sciences sector, and it is the product of BIOTECanada's consultations with stakeholders across Canada.
June 04 2009 Human Immunology research gets boost with appointment of U of T Chair
TORONTO Vaccine research and the study of human immunology at the University of Toronto will be significantly enhanced with the appointment of Professor Tania Watts as the new sanofi pasteur Chair in Human Immunology.
May 26 2009 ImmunoVaccine Technologies Partners with FIT Biotech to advance a therapeutic HIV vaccine
Halifax, Nova Scotia – ImmunoVaccine Technologies Inc. (IVT), a Canadian vaccine development company, announced a research partnership with FIT Biotech, a Finland-based, clinical stage company that develops DNA vaccines. This research will formulate FIT Biotech’s GTU® MultiHIV DNA plasmid with IVT’s DepoVax™ vaccine delivery system to advance a therapeutic HIV vaccine.
May 20 2009 Blood Transfusion Service in France Completes 20,000 Tests and Establishes Amorfix EP-vCJD™ Test in a Second Blood Center
Amorfix announced it has initiated the second phase of its large-scale study in France to demonstrate the feasibility of routine testing of blood donations for vCJD. Amorfix’s EP-vCJD™ test has been transferred to the Etablissement Français du Sang de Pyrénées Méditerrannée (EFS-PM) in Montpellier, France for the testing of an additional 20,000 blood donor samples.
May 13 2009 AMORFIX CLOSES $3.3 MILLION PRIVATE PLACEMENT
TORONTO, Ontario – April 29, 2009 – Amorfix Life Sciences Ltd. announced today that it has closed a non-brokered private placement, pursuant to which a total of 5,146,300 units (Units) were issued at a price of $0.65 per Unit for gross proceeds of $3,345,095. The size of the offering was increased from the amount previously announced to accommodate over-subscriptions.
April 14 2009 Molecular Templates Inc. Secures $2.5 million in Series A Financing from Santé Ventures
AUSTIN, TX-April 10, 2009-Molecular Templates Inc. (MTI), a biopharmaceutical company with a novel protein platform for the development of new cancer therapeutics, today announced it has secured $2.5 million in financing from Santé Ventures. Proceeds from this financing will be used to continue product development and conduct human clinical trials.
April 06 2009 Therapure Biopharma Aaeptic Fill Finishing Services
Therapure Biopharma continues to make strides to become a global contract development and manufacturing organization. Based in Toronto, Canada, Therapure Biopharma operates a state of the art 130,000 square foot flexible facility which was validated to GMP standards in 2008.
February 27 2009 ImmunoVaccine Technologies Signs Agreement with National Institutes of Health to Explore Vaccines for HIV and Malaria
Halifax, Nova Scotia; February 25, 2009 – ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, has signed a collaborative agreement with the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH), in Maryland, USA. The research collaboration involves formulating NIAID antigens in DepoVax™, IVT’s vaccine enhancement system, and exploring potential vaccines for HIV and malaria.
January 28 2009 Gowlings Student Essay Contest
Gowlings Student Essay Contest: Enter by March 31, 2009 for your chance to win your tuition up to $5000. Open to Canadian high school students attending a Canadian post secondary institution in a life sciences-related field.

January 14 2009 Mohawk College Biotechnology and Health Biotechnology Internship Program
Mohawk Biotechnology and Health Biotechnology interns will be available for employment beginning in January 2009. We invite business and industry to employ a student and add trained, enthusiastic employees to your staff.

January 14 2009 Confidence in the face of turmoil PriceWaterhouseCoopers
Difficult economic conditions around the world have encouraged many executives to look at alternative service delivery models like outsourcing and offshoring as a means of addressing various short- and long-term business concerns.
December 01 2008 Call for Volunteers to support planning of the 2009 Canadian Science Policy Conference 2009 Canadian Science Policy Conference
The Organizing Committee of the 2009 Canadian Science Policy Conference is seeking young and energetic volunteers to join the Organizing Committee and/or serve on sub-committees to support the planning of this national-level conference, to be held in Toronto in October 2009. Sub-committees include Finance, Logistics, Advertisement & Communication, Website & IT, Revenue Development, and Evaluation. Previous experience in event planning would be considered an asset, but is not required. For more information please contact Mehrdad Hariri. In near future the website www.sciencepolicy.ca will present the details of the conference. Click Here to Read Full Article
December 01 2008 The Golden Horseshoe Bioscience Network Blog
Do you want to give your two cents on ideas and thoughts in current news from Biotech, Pharma, Agriculture, or other related fields? Then write for the GHBN blog! Send your ideas and articles to ghblog@ghbn.org
October 28 2008 Therapure Biopharma Inc. announces collaboration with Induce Biologics Inc
Thomas Wellner, President and CEO of Therapure BioPharma Inc. and Dr. Cameron Clokie, President and CEO of Induce Biologics Inc. announced a development partnership utilizing an innovative approach to the production and manufacture of selected growth factors for stimulating bone regeneration. Click Here to Read Full Article
April 03 2008 Biotech-Pharma Deals Get No Respect
It just took me ages to write a simple article for this blog, which talks about the recent deal between Eli Lilly Lilly and Co. and one of our leading tenants, Transition Therapeutics.
March 05 2008 BIOTECanada Gold Leaf Awards
As a celebration of Canadian innovation, BIOTECanada's Gold Leaf Awards program is your opportunity to recognize both companies and individuals that have made significant achievements to our industry. Launched in 2001, these prestigious awards are given annually by Canada’s national biotechnology industry association.
February 19 2008 Sanofi Pasteur Donates Nearly $4 Million to Fund Vaccine Research that is Unique in Canada
Chair of the IWK Health Centre Foundation, Heather Sutherland, and President and CEO of the IWK Health Centre, Anne McGuire, today announced a $3.8 million donation to the Canadian Center for Vaccinology from sanofi pasteur, the vaccine division of sanofi-aventis Group. The multi-million dollar donation will be used to support human vaccine research that is unique in Canada.
October 31 2007 Outstanding Canadian Teachers Will Be Recognized in Communities Where Amgen Operates
MISSISSAUGA, ON. (Nov. 1, 2007) – Amgen Canada today announced that, for the first time, the Amgen Award for Science Teaching Excellence (AASTE) will be open to teachers in Canada. The award is designed to recognize and honour extraordinary science teachers at the K-12 level in British Columbia and Ontario where Amgen has facilities, who significantly impact their students through exemplary science teaching and who achieve demonstrated results in student learning.